Can an endometrioma (a cyst related to endometriosis) produce elevated Cancer Antigen 125 (CA 125) markers in women with endometriosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Endometriomas Produce Elevated CA-125 Markers?

Yes, endometriomas commonly produce elevated CA-125 levels, particularly in advanced endometriosis with cystic ovarian involvement, and this elevation should not automatically raise concern for malignancy in premenopausal women with clinical features consistent with endometriosis. 1

Mechanism and Patterns of CA-125 Elevation in Endometriosis

Source of CA-125 Production

  • CA-125 is expressed by both normal (eutopic) and abnormal (ectopic) endometrial tissue, making endometriomas a direct source of this marker 2
  • In women with cystic ovarian endometriosis (endometriomas), plasma CA-125 concentrations are markedly elevated 2, 3
  • The elevation reflects the presence of endometrial-type tissue within the ovarian cyst wall that actively produces CA-125 2

Cyclic Variation in Endometriosis

  • Women with advanced endometriosis show increased CA-125 concentrations toward the end of the luteal phase and during menstruation, but not during follicular and early luteal phases 2
  • This cyclic pattern is not observed in women without endometriosis, making it a distinguishing feature 2
  • Women with minimal or mild endometriosis typically show no elevation or only slight elevation in the luteal phase 3

Clinical Significance by Disease Severity

Marked Elevation in Specific Endometriosis Types

  • Cystic ovarian endometriosis (endometriomas): Markedly elevated CA-125 levels are characteristic 2, 3
  • Deeply infiltrating endometriosis: CA-125 can diagnose this condition with 36% sensitivity and 87% specificity, with particular utility for the most severe types (II and III) 2
  • Minimal or mild endometriosis: CA-125 is typically not elevated or only slightly elevated, consistent with the concept that minimal disease may represent a normal intermittent condition rather than true disease 3

Extremely High Levels Can Occur

  • Case reports document extremely elevated CA-125 levels (sometimes mimicking ovarian cancer levels) in patients with stage IV endometriosis and bilateral endometriomas 4, 5
  • Leaking endometriomas can produce profoundly elevated CA-125 levels that might otherwise suggest malignancy 5

Diagnostic Utility of CA-125 in Endometriosis

Differentiating Endometriomas from Other Cysts

  • Measurement of CA-125 in ovarian cyst fluid is the method of choice to differentiate a cystic corpus luteum from an ovarian endometriotic cyst 2
  • This distinction addresses a frequent and difficult clinical problem in gynecology 2

Role in Unexplained Pelvic Pain

  • CA-125 assay may be advocated in all women with unexplained pelvic pain as an aid in diagnosing deeply infiltrating endometriosis, given the strong association between deep endometriosis and pelvic pain 2
  • The marker is particularly helpful as an additional parameter to diagnose "endometriotic disease" (deep endometriosis and cystic ovarian endometriosis) in patients with chronic pelvic pain 3

Monitoring Treatment Response

  • Following surgical excision of endometriosis, CA-125 can monitor the completeness of surgery 2
  • Elevated plasma CA-125 after treatment suggests incomplete treatment or disease recurrence 3

Critical Clinical Context: Avoiding Misinterpretation

Premenopausal Women with Suspected Endometriosis

  • An elevated CA-125 in a premenopausal patient with an intermediate-risk lesion and clinical scenario highly suspicious for endometriosis should not unnecessarily elevate concern for malignancy 6, 1
  • The American College of Radiology O-RADS committee emphasizes that tumor marker evaluation should be individualized, specifically acknowledging that endometriosis can cause CA-125 elevation that might otherwise suggest malignancy 6, 1

Multiple Tumor Markers May Be Elevated

  • In addition to CA-125, endometriomas and leiomyomas can elevate CA 19-9 and chromogranin A (CgA) 7
  • Some patients with endometriosis only have elevated CA 19-9 or CgA without CA-125 elevation 7
  • Combined elevation of CA-125 and CA 15-3 has been reported in advanced endometriosis, though this is less common 4

Common Pitfalls to Avoid

False Reassurance in Postmenopausal Women

  • A normal CA-125 level may provide false reassurance in a postmenopausal woman with an intermediate- or high-risk ovarian lesion (O-RADS 4 or 5) 6
  • In postmenopausal women, the absence of functional ovarian activity means persistent masses warrant closer evaluation regardless of CA-125 levels 6

Other Benign Causes of Elevation

  • CA-125 has limited specificity and can be elevated in pelvic inflammatory disease, adenomyosis, menstruation, other benign cysts, cirrhosis, and following radiotherapy 6, 8, 1
  • Cirrhosis with ascites universally elevates CA-125 because mesothelial cells under pressure from fluid produce the antigen 8

Not a Screening Tool

  • CA-125 is not a good marker for screening or diagnosing minimal endometriosis 3
  • Only 50% of stage I ovarian cancers produce elevated CA-125, making it a poor screening tool for early disease 8

References

Guideline

CA125 Elevation in Endometriosis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

CA 125 in the management of endometriosis.

European journal of obstetrics, gynecology, and reproductive biology, 1993

Research

CA125 and endometriosis.

Human reproduction update, 1995

Research

Elevated CA 125 in a CASE of Leaking Endometrioma.

Case reports in obstetrics and gynecology, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cancers Associated with Elevated CA-125 Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.